Introduction 38 The Rickettsia are a genus of obligate intracellular alphaproteobacteria that are 39 divided into four groups -the spotted fever group (SFG), typhus group (TG), ancestral 40 group (AG), and transitional group (TRG) [1] . They inhabit arthropods (ticks, fleas, and 41 mites), and many can be transmitted to humans and other mammals. Pathogenic form of spotted fever in humans [3, 4] , is emerging as a model organism to study SFG 48 rickettsial pathogenesis. R. parkeri can be studied under BL2 conditions and has animal 49 models of pathogenesis that mimic aspects of human infection [5, 6] . Furthermore, the 50 R. parkeri life cycle closely matches that of the more virulent SFG species R. rickettsii 51 [7, 8] , the causative agent of Rocky Mountain spotted fever. Like its more virulent 52 relative, R. parkeri invades non-phagocytic cells and is taken into a primary phagocytic 53 vacuole [9] . They then break out of this vacuole and enter the cytosol to replicate and 54 grow [10] . R. parkeri and many other Rickettsia species also hijack the host cell actin 55 cytoskeleton to polymerize actin tails and undergo actin-based motility [11] [12] [13] . During 56 spread, motile R. parkeri move to a host cell-cell junction but then lose their actin tails 57 before entering into a short (~1 µm) plasma membrane protrusion that is subsequently 58 engulfed into the neighboring cell. The bacterium then lyses the double-membrane 59 secondary vacuole to enter the neighboring cell cytosol and begin the process again 60 Transposon mutagenesis in R. parkeri 93 R. parkeri Portsmouth strain was a gift from Dr. Chris Paddock (Centers for 94 Disease Control and Prevention). Wild-type R. parkeri were expanded and purified by 95 centrifugation through a 30% MD-76R solution, as previously described [14] . The 96 pMW1650 plasmid carrying the Himar1 mariner-based transposon [16] (a gift from Dr. 97 David Wood, University of South Alabama) was used to generate R. parkeri strains 98 carrying transposon insertions. To isolate small plaque mutants, a small-scale 99 electroporation protocol was designed. First, a T75 cm 2 flask of confluent Vero cells was 100 infected with approximately 10 7 WT R. parkeri. Three days post-infection, when Vero 101 cells were at least 90% rounded, they were scraped from the flask. Infected cells were 102 spun down for 5 min at 1800 x g at 4˚C and resuspended in 3-6 ml K-36 buffer. To 103 mechanically disrupt infected cells and release bacteria, cells were either passed 6 through a 27.5 gauge syringe needle 10 times, or vortexed at ~2900 rpm using a Vortex 105 Genie 2 (Scientific Industries Inc.) in a 15 ml conical tube containing 2 g of 1 mm glass 106 beads, with two 30 s pulses and 30 s incubations in ice after each pulse. This bead 107 disruption procedure was adopted for a majority of the screen because it was faster and 108 reduced the possibility of a needle stick. Host cell debris was pelleted for 5 min at 200 x 109 g at 4˚C. The supernatant containing R. parkeri was transferred to 1.5 ml 110 microcentrifuge tubes and spun for 2 min at 9000 x g at 4˚C. The bacterial pellets were 111 then washed three times in cold 250 mM sucrose, resuspended in 50 µl cold 250 mM 112 sucrose, mixed with 1 µg of pMW1650 plasmid, placed in a 0.1 cm cuvette, and 113 electroporated at 1.8 kV, 200 ohms, 25 µF, 5 ms using a Gene Pulser Xcell (Bio-Rad). 114 Bacteria were immediately recovered in 1.2 ml brain heart infusion (BHI) media. To 115 infect confluent Vero cells in 6-well plates, media was removed from each well, and 116 cells were washed with phosphate-buffered saline (PBS). 100 µl of electroporated 117 bacteria was added per well, and plates were placed in a humidified chamber and 118 rocked for 30 min at 37˚C. An overlay of DMEM with 5% FBS and 0.5% agarose was 119 added to each well. Infected cells were incubated at 33˚C, 5% CO 2 for 24 h at which 120 point a second overlay was added containing rifampicin (Sigma) to a final concentration 121 200 ng/ml to select for transformants. After at least 3 or 4 d, plaques were visible by eye 122 in the cell monolayer, and plaques smaller or bigger relative to neighboring plaques 123 were selected for further analysis. 124 To isolate and amplify mutant strains and map the sites of transposon insertion, 125 plaques were picked and resuspended in 200 µl of BHI. Media was aspirated from 126 confluent Vero cells in 6-well plates, and the isolated plaque resuspension was used to 7 infect the cells at 37˚C for 30 min with rocking. Then 3 ml DMEM with 2% FBS and 200 128 ng/ml rifampicin was added to each well, and infections progressed until monolayers 129 were fully infected. Infected cells were isolated as described above using mechanical 130 disruption, except that bacteria were immediately resuspended in BHI without a sucrose 131 wash and stored at -80˚C. 
Results
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Design of an improved transposon mutagenesis scheme 154 We used the pMW1650 plasmid, which carries a Himar1 mariner-based ). The first reported application of this system in R. prowazekii [16] and R. rickettsii 159 [18] yielded some transposon mutants, but we sought to improve the mutagenesis 160 scheme to increase the chances of identifying genes important for infection. Therefore, 161 we developed a simple and rapid procedure to extract bacteria from infected host cells. 162 In the past, we had purified R. parkeri from infected host cells using an hours-long 163 process involving mechanical disruption and density gradient centrifugation prior to 164 electroporation [21] . We designed a new procedure to isolate and electroporate bacteria 165 and re-infect host cells in under an hour. To mechanically disrupt infected cells, we 166 either passed infected cells through syringe needle or vortexed cells in the presence of 167 1 mm glass beads. Samples were then spun at low speed for 5 min to pellet host cell 168 debris, followed by a 2 min high-speed spin to pellet bacteria. Rickettsia were then 169 quickly washed 2-3 times in cold sucrose prior to electroporation. To identify genes involved in infection, we screened for transformants that 176 showed altered plaque size and/or morphology ( Fig 1B) . We predicted that plaque size 177 changes would result from defects at different stages of the rickettsial life cycle, 178 including in intracellular growth, replication, motility, and/or spread. To screen for such 179 mutants, pMW1650-electroporated bacteria were immediately used to setup plaque 180 assays in the presence of rifampicin to select for transformants. Plaque size was 181 monitored visually over the course of 3-9 days, and those displaying a small plaque (Sp) 182 or big plaque (Bp) phenotype relative to their neighbors were selected for expansion. 183 After independently repeating this process 7 times, 120 Sp mutant and 2 Bp mutants 184 were selected for further analysis, as detailed below. 185 186 Expansion and mapping of the transposon mutants 187 To expand the isolated transformants, plaques were picked and transferred to 188 uninfected host cells to propagate each bacterial strain. Once the host cells were >75% 189 infected, Rickettsia were purified using the rapid isolation procedure outlined above. 190 Nine isolates did not grow in this expansion procedure, possibly due to a lack of live 191 bacteria in the original plaque or poor isolation of the infected cells. The remaining 192 transformants could be expanded, and for these the transposon insertion site was 193 mapped using a semi-random nested PCR protocol. In short, the junctions between the 194 transposon and the flanking genomic regions were amplified via two nested PCR 195 reactions using transposon-specific and universal primers ( Fig 1C) . PCR products were 196 sent directly for sequencing. Mapping of the transposon insertion sites to the R. parkeri 197 chromosome (accession number CP003341) revealed no preference for specific 198 regions ( Fig 1D) , similar to what was observed in R. rickettsii [18, 19] and R. prowazekii 199 [16, 18] . Using this procedure, we identified the transposon insertion sites for 106 200 mutants. For 6 isolates the transposon insertion site could not be mapped, and the 201 strains did not express GFP uv (data not shown), suggesting these were spontaneous 202 rifampicin-resistant strains. Of the 106 transposon mutations mapped, 81 were within 203 the coding regions of 75 distinct genes and 25 were in intergenic regions (Table 1) . 204 Mutants of interest (Sp2, Sp34, and Sp19) were further purified and expanded for In our study, we selected for mutants that showed an altered plaque size 233 phenotype in infected host cell monolayers. Transposon mutations may cause a small 234 plaque phenotype due to any number of defects, including: poor bacterial replication, 235 reduced access to or survival within the cytosol, impaired cytosolic actin-based motility, 236 and defective cell-to-cell spread. It was thus not surprising that we identified genes with 237 a diverse set of predicted functions. Many genes with products predicted to perform intracellular infection [14, 20] . For example, we previously described transposon 243 mutations that disrupt the rickA (Sp34) and sca2 (Sp2) genes and showed that these 244 gene products are required for two independent phases of R. parkeri actin-based 245 motility [20] . We also identified a transposon insertion (Sp19) in sca4 gene and showed 246 this encodes a secreted effector that promotes cell-to-cell spread [14] . 247 Other genes mutated in this screen have been suggested to play critical roles 248 during the infectious life cycle of other Rickettsia species but have yet to be 249 characterized in R. parkeri. For example, we isolated transposon insertion mutants in 250 the ompA (Sp80) and ompB (Sp106) genes, encoding the outer membrane proteins 251 OmpA and OmpB. Work with SFG species R. conorii and R. rickettsii showed that 252 OmpA and OmpB may regulate adhesion to and/or invasion of host cells [22] [23] [24] [25] . 253 However, some of this work relied on expression of these proteins in other bacterial 254 species because mutants were not available. Interestingly, targeted knockout of ompA in R. rickettsii via an LtrA group II intron retrohoming system revealed no clear 256 requirement for OmpA in invasion [26], suggesting it alone is not necessary. This 257 highlights the importance of studying loss-of-function mutants to reveal gene function. 258 The fact that ompA and ompB mutants exhibit a small plaque phenotype suggest 259 additional functions of these proteins, putative indirect effects of the truncated products, isolated a strain with a transposon insertion mutation in the fifth VirB6-like gene, rvhB6e 281 (Sp9). This mutant will prove useful to explore the function of the T4SS in rickettsial 282 infection. 283 Finally, we identified 20 strains, each carrying a transposon insertion disrupting a 284 gene encoding a hypothetical protein. One of these caused a big plaque phenotype, 285 suggesting enhanced growth or cell-to-cell spread. Further study of these mutants has 286 the potential to reveal the function of these uncharacterized gene productions during 287 rickettsial infection. 288 Overall, our mutant collection provides an important resource that can be used to 289 uncover key bacterial players that regulate rickettsial interactions with their host cells. 290 By streamlining the ease of mutant isolation as described here, investigators can begin 291 expanding the available toolkit to generate more Rickettsia mutants. This will also allow 292 for more direct analysis of gene function in the rickettsiae without the reliance on 293 introducing genes into heterologous organisms. This forward genetics approach has the 294 potential to reveal new insights into rickettsial biology and pathogenesis; however, 295 limitations remain. For example, because the rickettsiae are obligate intracellular 296 pathogens, screens such as these are unlikely to reveal genes that are essential for 297 invasion or intracellular growth. Therefore, we cannot necessarily assess the relative 298 importance of genes not identified in forward genetic screens. Additionally, the reported 299 protocol still has limits with regard to electroporation efficiency and recovery on host 300 cells, which makes it harder to adapt for large-scale mutagenesis work. Further 301 advancements in rickettsial genetic methods will be necessary to complement our work 302 and more effectively probe the molecular mechanisms of all genes whose products may 303 control critical host-pathogen interactions. 
